Primary Site >> Colorectal Cancer
Gene >> CADM1
|
|
|
|
|
|
|---|---|---|---|---|---|
|
Ref: The high lysability by LAK cells of colon-carcinoma cells resistant to doxorubicin is associated with a high expression of ICAM-1, LFA-3, NCA and a less-differentiated phenotype. PMID: 1706327 |
Ref: Aberrant DNA methylation occurs in colon neoplasms arising in the azoxymethane colon cancer model. PMID: 19777566 Ref: MS-MLPA reveals progressive age-dependent promoter methylation of tumor suppressor genes and possible role of IGSF4 gene in colorectal carcinogenesis of microsatellite instable tumors. PMID: 19995226 |
Ref: CADM1/TSLC1 inactivation by promoter hypermethylation is a frequent event in colorectal carcinogenesis and correlates with late stages of the disease. PMID: 20340131 |
Ref: Down-regulation of tumor suppressor in lung cancer 1 (TSLC1) expression correlates with poor prognosis in patients with colon cancer. PMID: 22851235 |
Ref: miR-214 and hypoxia down-regulate Necl-2/CADM1 and enhance ErbB2/ErbB3 signaling. PMID: 23301758 Ref: Cohypermethylation of p14 in combination with CADM1 or DCC as a recurrence-related prognostic indicator in stage I esophageal squamous cell carcinoma. PMID: 23310950 Ref: Gene methylation in rectal cancer: predictive marker of response to chemoradiotherapy? PMID: 23702823 |
Ref: Deregulated Mucosal Immune Surveillance through Gut-Associated Regulatory T Cells and PD-1(+) T Cells in Human Colorectal Cancer. PMID: 29581358 |